Medifast (MED) Cash & Current Investments (2010 - 2026)

Medifast (MED) has 17 years of Cash & Current Investments data on file, last reported at $168.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 2.64% year-over-year to $168.9 million; the trailing twelve-month figure through Mar 2026 stood at $168.9 million (up 2.64% YoY), and the FY2025 full-year result was $167.3 million, up 3.04% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $168.9 million, up from $167.3 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $173.5 million in Q3 2025 and bottomed at $61.1 million in Q2 2022.
• The 5-year median for Cash & Current Investments is $157.8 million (2023), against an average of $141.7 million.
• The widest annual swing landed in 2022, when Cash & Current Investments slumped 69.07%; it then surged 141.37% in 2023.
• A 5-year view of Cash & Current Investments shows it stood at $87.7 million in 2022, then surged by 71.1% to $150.0 million in 2023, then climbed by 8.2% to $162.3 million in 2024, then increased by 3.04% to $167.3 million in 2025, then gained by 1.0% to $168.9 million in 2026.
• The last three Cash & Current Investments figures came in at $168.9 million (Q1 2026), $167.3 million (Q4 2025), and $173.5 million (Q3 2025), per Business Quant data.

Peer Comparison